Cargando…
Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
OBJECTIVES: To review the available systemic treatments for women with recurrent ovarian cancer. METHODS: A literature review was conducted for recurrent ovarian cancer articles in English, including randomized trials, Phase II trials, or reviews. RESULTS: We discuss the efficacy and toxicity outcom...
Autores principales: | Elit, Laurie, Hirte, Hal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585576/ https://www.ncbi.nlm.nih.gov/pubmed/23459506 http://dx.doi.org/10.2147/OTT.S30238 |
Ejemplares similares
-
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma
por: Hirte, Hal, et al.
Publicado: (2021) -
Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007) -
Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline
por: Hirte, Hal, et al.
Publicado: (2022) -
Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma
por: Hirte, Hal W
Publicado: (2013) -
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)